[Retracted] mRNA-Modified FUS/NRF2 Signalling Inhibits Ferroptosis and Promotes Prostate Cancer Growth

Figure 8

Effects of Erastin, ferroptosis rroptosis death inhibitors, and FUS knockdown on NRF2 and HO-1. (a) NRF2 expression in LNCaP cells after treatment. (b) NRF2 expression in C42 cells after treatment. (c) HO-1 expression in LNCaP cells after treatment. (d) HO-1 expression in C42 cells after treatment.

(a)

(b)

(c)

(d)